These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23525702)

  • 1. Effect of adding a sleep dimension to the EQ-5D descriptive system: a "bolt-on" experiment.
    Yang Y; Brazier J; Tsuchiya A
    Med Decis Making; 2014 Jan; 34(1):42-53. PubMed ID: 23525702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.
    Longworth L; Yang Y; Young T; Mulhern B; Hernández Alava M; Mukuria C; Rowen D; Tosh J; Tsuchiya A; Evans P; Devianee Keetharuth A; Brazier J
    Health Technol Assess; 2014 Feb; 18(9):1-224. PubMed ID: 24524660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Impact of Adding a Respiratory Dimension to the EQ-5D-5L.
    Hoogendoorn M; Oppe M; Boland MRS; Goossens LMA; Stolk EA; Rutten-van Mölken MPMH
    Med Decis Making; 2019 May; 39(4):393-404. PubMed ID: 31092111
    [No Abstract]   [Full Text] [Related]  

  • 5. Filling the psycho-social gap in the EQ-5D: the empirical support for four bolt-on dimensions.
    Chen G; Olsen JA
    Qual Life Res; 2020 Nov; 29(11):3119-3129. PubMed ID: 32648198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of the development and testing of additional dimensions for the EQ-5D descriptive system.
    Kangwanrattanakul K; Phimarn W
    Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):431-443. PubMed ID: 31244348
    [No Abstract]   [Full Text] [Related]  

  • 7. An exploratory study to test the impact on three "bolt-on" items to the EQ-5D.
    Yang Y; Rowen D; Brazier J; Tsuchiya A; Young T; Longworth L
    Value Health; 2015 Jan; 18(1):52-60. PubMed ID: 25595234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling a preference-based index for EQ-5D-3L and EQ-5D-3L + Sleep using a Bayesian framework.
    Kharroubi SA; Beyh YS; Brazier J; Yang Y
    Qual Life Res; 2020 Jun; 29(6):1495-1507. PubMed ID: 32016681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
    Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
    Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
    Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
    Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Exploratory Study on Using Principal-Component Analysis and Confirmatory Factor Analysis to Identify Bolt-On Dimensions: The EQ-5D Case Study.
    Finch AP; Brazier JE; Mukuria C; Bjorner JB
    Value Health; 2017 Dec; 20(10):1362-1375. PubMed ID: 29241896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
    Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
    J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study.
    Santos M; Cintra MA; Monteiro AL; Santos B; Gusmão-Filho F; Andrade MV; Noronha K; Cruz LN; Camey S; Tura B; Kind P
    Med Decis Making; 2016 Feb; 36(2):253-63. PubMed ID: 26492896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK.
    Swinburn P; Lloyd A; Boye KS; Edson-Heredia E; Bowman L; Janssen B
    Value Health; 2013 Dec; 16(8):1156-62. PubMed ID: 24326169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran.
    Goudarzi R; Sari AA; Zeraati H; Rashidian A; Mohammad K; Amini S
    Value Health Reg Issues; 2019 May; 18():170-175. PubMed ID: 31096140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [General population time trade-off values for 42 EQ-5D health states in South Korea].
    Jo MW; Lee SI
    J Prev Med Public Health; 2007 Mar; 40(2):169-76. PubMed ID: 17426430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.
    Rand-Hendriksen K; Augestad LA
    Value Health; 2012; 15(5):777-82. PubMed ID: 22867789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.